CoChat

Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Background Analyses of some randomised trials show that calcium-channel blockers reduce the risk of stroke more than expected on the basis of mean blood pressure alone and that beta blockers are less effective than expected. We aimed to investigate whether the effects of these drugs on variability in blood pressure might explain these disparities in effect on stroke risk.Methods The Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm (ASCOT-BPLA) compared amlodipine-based regimens with atenolol-based regimens in 19 257 patients with hypertension and other vascular risk factors and the Medical Research Council (MRC) trial compared atenolol-based and diuretic-based regimens versus placebo in 4396 hypertensive patients aged 65-74 years. We expressed visit-to-visit variability of blood pressure during follow-up in the two trials as standard deviation (SD) and as transformations uncorrelated with mean blood pressure. For ASCOT-BPLA, we also studied within-visit variability and variability on 24 h ambulatory blood-pressure monitoring (ABPM).Results In ASCOT-BPLA, group systolic blood pressure (SBP) SD was lower in the amlodipine group than in the atenolol group at all follow-up visits (p<0.0001), mainly because of lower within-individual visit-to-visit variability. Within-visit and ABPM variability in SBP were also lower in the amlodipine group than in the atenolol group (all p<0.0001). Analysis of changes from baseline showed that variability decreased over time in the amlodipine group and increased in the atenolol group. The lower risk of stroke in the amlodipine group (hazard ratio 0.78, 95% CI 0.67-0.90) was partly attenuated by adjusting for mean SBP during follow-up (0.84, 0.72-0.98), but was abolished by also adjusting for within-individual SD of clinic SBP (0.99, 0.85-1.16). Findings were similar for coronary events. In the ABPM substudy, reduced variability in daytime SBP in the amlodipine group (p<0.0001) partly accounted for the reduced risk of vascular events, but reduced visit-to-visit variability in clinic SBP had a greater effect. In the MRC trial, group SD SBP and all measures of within-individual visit-to-visit variability in SBP were increased in the atenolol group compared with both the placebo group and the diuretic group during initial follow-up (all p<0.0001). Subsequent temporal trends in variability in blood pressure during follow-up in the atenolol group correlated with trends in stroke risk.Interpretation The opposite effects of calcium-channel blockers and beta blockers on variability of blood pressure account for the disparity in observed effects on risk of stroke and expected effects based on mean blood pressure. To prevent stroke most effectively, blood-pressure-lowering drugs should reduce mean blood pressure without increasing variability; ideally they should reduce both.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(10)70066-1

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. Cuffe, 2005, Medium-term variability in systolic blood pressure is an independent predictor of stroke, Cerebrovasc Dis, 19, 51

Cited by

See all 690

Metadata

Authors
Rothwell, P. M., Howard, S. C., Dolan, E., O'Brien, E., Dobson, J. E., Dahlöf, B., Poulter, N. R., & Sever, P. S.
Affiliations
  • John Radcliffe Hospital (GB)
  • Connolly Hospital Blanchardstown (IE)
  • University College Dublin (IE)
  • Imperial College London (GB)
Corresponding author
Rothwell, Peter M
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2010-05
Volume
9
Issue
5
Pages
469-480
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2151273903
Cited by
690
References
43
Citations by year
2026: 21 · 2025: 24 · 2024: 22 · 2023: 33 · 2022: 34 · 2021: 43 · 2020: 39 · 2019: 35 · 2018: 39 · 2017: 56 · 2016: 55 · 2015: 52 · 2014: 56 · 2013: 62 · 2012: 43
FWCI
39.72
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0508-10116)
  • British Heart Foundation
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
beta-blockers, calcium channel blockers, blood pressure variability, within-person variability, stroke risk, amlodipine, atenolol, hypertension, ambulatory blood pressure monitoring, visit-to-visit variability, coronary events, vascular risk factors, older adults, MRC trial, diuretics, blood pressure reduction
MeSH terms
Adrenergic beta-Antagonists, Adult, Aged, Antihypertensive Agents, Atenolol, Blood Pressure, Calcium Channel Blockers, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Risk, Amlodipine, Blood Pressure Monitoring, Ambulatory, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. https://app.cochat.ai/papers/10.1016/s1474-4422(10)70066-1
The paper
Rothwell, P. M., Howard, S. C., Dolan, E., O'Brien, E., Dobson, J. E., Dahlöf, B., Poulter, N. R., & Sever, P. S. (2010). Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(10)70066-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.